Results 1 to 10 of about 276,394 (173)
J Infect Dis, 2021 Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn J +3 more
europepmc +2 more sources
The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab. [PDF]
Crohns Colitis 360, 2020 Background Patients with inflammatory bowel disease (IBD) have an elevated risk for infection which is further increased by immunosuppressive medications.
Harrington JE +4 more
europepmc +2 more sources
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
Viruses, 2023 Vaccination has been confirmed to be the safest and, sometimes, the only tool of defense against threats from infectious diseases. The successful history of vaccination is evident in the control of serious viral infections, such as smallpox and polio ...
Ashraf Elbahrawy +7 more
doaj +2 more sources
Expert Review of Vaccines, 2008 The global disease burden associated with hepatitis A virus (HAV) is expected to increase in the coming years due to a shift in the epidemiological pattern of the disease. A decrease in the prevalence of natural immunity is leading to an increased number of adolescents and adults susceptible to a disease that is associated with greater morbidity ...
H. Nothdurft
openaire +3 more sources
Development of new hepatitis E vaccines. [PDF]
Hum Vaccin Immunother, 2018 Hepatitis E virus (HEV) infection is an emerging zoonotic disease posing a severe threat to public health in the world, especially to pregnant women. Currently, no specific treatments are available for HEV infection.
Cao Y, Bing Z, Guan S, Zhang Z, Wang X.
europepmc +2 more sources
Hepatitis C Vaccines, Antibodies, and T Cells. [PDF]
Front Immunol, 2018 The development of vaccines that protect against persistent hepatitis C virus (HCV) infection remain a public health priority. The broad use of highly effective direct-acting antivirals (DAAs) is unlikely to achieve HCV elimination without vaccines that ...
Shoukry NH.
europepmc +2 more sources
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000. [PDF]
Stud Hist Philos Biol Biomed Sci, 2017 The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system.
Huzair F, Sturdy S.
europepmc +2 more sources
Human Vaccines & Immunotherapeutics, 2021 Hepatitis A virus (HAV) infections continue to represent a significant disease burden causing approximately 200 million infections, 30 million symptomatic illnesses and 30,000 deaths each year.
Christian Herzog +2 more
doaj +2 more sources
Vaccination Strategies Against Hepatic Diseases: A Scoping Review [PDF]
VaccinesBackground/Objectives: Viral hepatitis remains a significant global cause of chronic liver disease, highlighting the importance of effective vaccination strategies. This review assesses recent evidence on vaccine safety and effectiveness.
Zahra Beyzaei +3 more
doaj +2 more sources
Vaccines, 2016 Viral hepatitis is a serious health problem all over the world. However, the reduction of the morbidity and mortality due to vaccinations against hepatitis A and hepatitis B has been a major component in the overall reduction in vaccine preventable ...
Sina Ogholikhan, Kathleen B. Schwarz
doaj +2 more sources